Citius Oncology Secures $18 Million in Direct Offering and Private Placement for Future Growth Citius Oncology successfully closes an $18 million capital raise through a direct offering and private placement aimed at accelerating commercialization of LYMPHIR.

Citius Oncology Secures $18 Million in Direct Offering and Private Placement for Future Growth #USA #Cranford #LYMPHIR #Citius_Oncology #Nasdaq_CTOR

Citius Oncology Secures $18 Million for Innovative Cancer Immunotherapy Launch Citius Oncology, a subsidiary of Citius Pharmaceuticals, announces an $18 million simultaneous registered direct offering and private placement to boost the launch of its cancer treatment, LYMPHIR.

Citius Oncology Secures $18 Million for Innovative Cancer Immunotherapy Launch #United_States #Cranford #LYMPHIR #Citius_Oncology #Nasdaq_CTOR